Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Highbank (TSX-V:HBK) Approaches Milestone First Production; Ready to Supply B.C. LNG and Port Infrastructure
VANCOUVER, British Columbia, Oct. 21, 2014 (GLOBE NEWSWIRE) -- The piling work for the load-out conveyor and mooring dolphins at Highbank Resources Ltd.'s (TSX-V:HBK) SPN aggregate mine was completed earlier this month and the conveyor sections and receiving hopper are now in place.
In the mine site area, stripping of the sand/silt layer immediately above the gravel deposit is continuing and crushing, washing and screening equipment is being prepared. Loading of the first barge is anticipated in the next two weeks.
The first barge to leave the new facility will be loaded with 1 inch crush destined for Prince Rupert.
In a recently distributed press release providing forward guidance, Highbank President and CEO Victor Bryant announced projected revenues of $27 million for fiscal 2015. First year pre-tax profits are projected at $11 million. Those estimates are based on pending orders and quotes submitted over the past few months. The full press release can be found on the company's website at www.highbankresources.com.
"It is of some import to note that the SPN project's total CapEx is under $8 million to access a $2.4 billion (NI 43-101 compliant) resource," states Bryant. "Although first production is slated for the end of October, we can disclose that we have already quoted on delivery in excess of 2 million tons of material."
To-date the company has submitted quotes for 1 million tons of material related to pipeline construction, 600,000 tons related to harbour expansion and 600,000 tons for first phase LNG infrastructure.
With a scarcity of aggregate in Alberta, additional quotes have been submitted for rail shipments back to that province for infrastructure builds.
In addition to quotes on near term projects, Highbank is working on securing business well into the future. Negotiations are underway to supply 2 million tons of aggregate for a pipeline project scheduled to begin construction late in 2016 or early 2017.
"Our business plan is based on existing projects," says Bryant.
While three quarters of Highbank's aggregate is destined for concrete, there is also significant demand for road building and soil stabilization.
"We can run a very profitable business as is, and when LNG construction begins, that will be bonus," adds Bryant.
Even before LNG projects get underway, a great deal of infrastructure will need to be built. A substantial increase in the region's workforce, both during construction and operation of the pipelines and terminals, will require housing, retail, recreation and support facilities. The Port of Prince Rupert is undergoing a massive infrastructure expansion, already valued in excess of $40 billion.
Availability of transportation corridors is an extremely important factor for marketability of aggregates. The SPN mine is located on the east side of the Portland Canal fjord on tidewater. Existing year round deep-water ports are located 38 miles north at Stewart and 72 miles south at Prince Rupert. This gives Highbank a major competitive advantage with the ability to ship product by high capacity barge while most competitors are required to truck.
The completion of the camp and load out facility will place Highbank in the enviable position of being the nearest, significant, quality construction aggregate deposit to the Port of Prince Rupert, B.C. and the other construction projects in the northwest area.
ALR Technologies (ALRT)Advocates For Sensible Medicare Reimbursement of Continuous Glucose Monitoring (CGM) for Diabetes Patients
Internet Monitoring More Cost Effective Than Continuous Glucose Monitoring (CGM) for Most Medicare Patients Says ALRT President Bill Smith
In a letter to Marilyn Tavenner, Administrator of the Center for Medicare and Medicaid Services (CMS), Bill Smith, President of ALR Technologies (OTCQB: ALRT) advocated for CMS reimbursement for continuous glucose monitoring systems (CGM) for Type 1 diabetes patients as well as higher-risk Type 2 patients. However, Smith argued that most Type 2 patients should first be encouraged to seek Internet-based remote chronic care management and then to step up to CGM if they don't achieve their health goals on the more cost-effective, Internet-based monitoring.
"There is no doubt that CGM should be made available to higher risk diabetes patients as this is a very valuable monitoring technology," said Smith. "However, for many other patients, I believe a sensible policy would be to reimburse first for Internet-based monitoring systems and then provide the CGM option for patients who fail on this less costly, Internet-based technology."
The complete text of the letter can be found here http://www.alrt.com/Media/Default/Page/CMSLetter.pdf
ALR Technologies has sponsored a clinical trial comparing Internet-based monitoring systems (IBGMS) with CGM in Type 2 diabetes patients. The results of that trial can be found here: http://alrt.com/hec/clinical-support
On November 1, CMS is expected to announce new rules for physician reimbursement in a broad range of treatments including management of chronic diseases such as diabetes. Among the proposed rules is a new payment schedule for remote chronic care management similar to the service that ALRT's Health-e-Connect system delivers.
iHookup Social (HKUP) Releases Investor Portal and Information Center
New Site to Provide Additional Information and Increased Transparency
CAMPBELL, CA--(Marketwired - Oct 20, 2014) - iHookup Social, Inc. (OTCQB: HKUP), a mobile -- social app that enables singles and the socially active to connect quickly and efficiently in the virtual world, offering local, real life 'hook-up' opportunities, is pleased to announce the availability of a new Investor Portal and Information Center for shareholders and interested parties.
The Investor Portal and Information Center is available at http://www.glntv.tv/ihookup
The new site is provided through the Company's previously announced partnership with the marketing firm Megacast http://www.megacast.co/megasite and offers numerous resources, video and company information about iHookup Social's business model and industry.
"It has always been our goal to continue providing increased understanding and transparency," stated Robert Rositano, CEO, iHookup Social. "We added Megacast to our team of partners to increase our visibility and awareness for the iHookup Social brand, our app and the general market opportunity for the company's business model. This Investor Portal extends beyond a simple power point presentation and serves as a useful destination for anyone who wants to learn more about iHookup Social's current market position, as well as our vision for the future."
From time to time, iHookup Social will provide market updates, news and additional information via its website www.ihookupsocial.com, the Company's Facebook page and others www.facebook.com/ihookupnow
iHookup Social, Inc.
iHookup Social, Inc. is a mobile Social Dating App positioned at the intersection of dating, social media and location-based connections.
About iHookup: iHookup endeavors to enable singles, groups and the socially active to connect quickly and efficiently with local, real life 'hook-up' opportunities. This is the iHookup difference. Not only does the company's ever-refining technology help create meaningful connections of all varieties; it also facilitates the real-life meeting and offering-up of locally relevant locations to engage these new connections. These participating venues complete a circle of service that allows iHookup Social to be both matchmaker and concierge, providing a unique opportunity for consumer brands to offer incentives to a growing network of socially active singles and mobile users. iHookup Social, where real people make real connections... and where real businesses pay to be their host. www.ihookupsocial.com
iHookup Social (OTCQB: HKUP), Receives Apple App Store Approval for New App Release
App Store Video Preview to Provide Expanded Visibility
CAMPBELL, CA--(Marketwired - Oct 9, 2014) - iHookup Social, Inc. (OTCQB: HKUP), a mobile - social app that enables singles, groups and the socially active to connect quickly and efficiently in the virtual world, offering local, real life 'hook-up' opportunities, is pleased to announce an extremely quick turn around and approval of its new iOS8 enhanced mobile app from the Apple App Store.
The latest version of the Company's app is now available for upgrade to its current registered user base of 393,000 as well all new customers joining the app for the first time. The array of futures now offered are iPhone 6, 6 plus and iOS8 optimized.
According to a Forbes article (Published on October 5, 2014) Apple is approaching sales of 20 million iPhone 6 and 6 plus models since releasing the new versions last month, showing significant adoption and upgrade rates by Apple customers.
"We are very pleased to learn of Apple's new device sales increasing rapidly and to have such an expeditious approval of our new version optimized for these devices," stated Robert Rositano, CEO, iHookup Social. "Not only are we excited about what our team believes is the best version of our app to date, we now have our accompanying video preview that appears in App Store right along with it. iHookup Social is in the first wave of Social apps to have taken advantage of this video preview feature and by increasing visibility, the opportunity to convert an interested viewer into an actual user is a unique advantage for the company."
From time to time, iHookup Social will provide market updates, news and additional information via its website www.ihookupsocial.com, the Company's Facebook page and others www.facebook.com/ihookupnow
http://www.glntv.tv/ihookup
iHookup Social, Inc.
iHookup Social, Inc. is a mobile Social Dating App positioned at the intersection of dating, social media and location-based connections.
About iHookup: iHookup endeavors to enable singles, groups and the socially active to connect quickly and efficiently with local, real life 'hook-up' opportunities. This is the iHookup difference. Not only does the company's ever-refining technology help create meaningful connections of all varieties; it also facilitates the real-life meeting and offering-up of locally relevant locations to engage these new connections. These participating venues complete a circle of service that allows iHookup Social to be both matchmaker and concierge, providing a unique opportunity for consumer brands to offer incentives to a growing network of socially active singles and mobile users.
iHookup Social, where real people make real connections... and where real businesses pay to be their host. www.ihookupsocial.com
Health-e-Connect: (ALRT) The FDA-Cleared System at the Forefront of Remote Diabetes Care
Richmond, VA / ACCESSWIRE / October 7, 2014 / ALR Technologies' (ALRT) new FDA-cleared Remote Patient Monitoring system may finally allow doctors and clinicians to receive reimbursement for remote chronic care management, and it could become one of the most influential platforms for managing diabetes. ALRT's Health-e-Connect is the only off-the-shelf chronic care system connecting diabetes patients with an experienced care team as well their own physicians - anywhere in the country - through a secure and trusted website. If the Centers for Medicare and Medicaid Services (CMS) proposed payment schedule is finalized on November 1, physicians would receive payments of $41.92 for up to 20 minutes of remote care each month.Implementation of the proposed reimbursement plan would pave the way for ALRT to begin invoicing and collecting revenue for its services for diabetes patients covered by Medicare.Capturing just 1% of the US Medicare market as it pertains to diabetes would represent up to $2.3 million per month in potential revenue to ALRT.
This revenue-producing system could decrease long-term healthcare costs, create compensation for physicians, and establish positive cash flow for ALRT.The company moving towards the revenue-generation stage is underscored by years of R&D and millions of dollars in investment to achieve FDA clearance and meet all HIPAA (Health Insurance Portability & Accountability Act) requirements to ensure patient data confidentiality, a duo of accomplishments that most potential competition has failed to obtain.
This is a unique patient monitoring program that's made leaps and strides in developing a profitable model for remote care for patients with chronic disease. With the high global cost of diabetes on the rise, ALRT is primed and positioned at the forefront of the burgeoning Remote Patient Care industry. Its system has already begun enrolling patients in the US in a bid to prove its commercial viability and replicate data from clinical trials demonstrating Health-e-Connect is influential in reducing A1c levels, which can have a meaningful impact on clinical outcomes in diabetes patients.
The Kansas City Metropolitan Physician Association (KCMPA), a Medicare Accountable Care Organization, represents the first large-scale commercial deployment of the Health-e-Connect remote management system. The goal is to lower high-risk glucose levels of some of KCMPA's most challenging diabetic patients. Importantly to ALRT stakeholders, KCMPA has agreed to negotiate a fee to be paid to ALRT for their use of the Health-e-Connect System beginning January 1, 2015 if the proposed CMS reimbursement rule is enacted.
"KCMPA is on the forefront of this wave of medical innovation," says ALRT President Bill Smith. With the system currently employed in a major medical facility, the next step is for ALRT to expand its model on a global scale.
"Diabetes is a huge issue. It's exploding in Latin America and in Asia; it's really a public health pandemic that's affecting the entire globe," Smith adds. 300 million people will be diagnosed with diabetes by the year 2025, according to the American Diabetes Association. The total cost of managing the disease in the US alone is up to $245 billion, including $176 billion in direct medical costs. Health-e-Connect addresses these costs by increasing patient's remote involvement, which helps reduce A1c, the gold standard in assessing diabetes control.
ALRT sits at the forefront of Remote Patient Monitoring with its Health-e-Connect system.ALRT has created a remote monitoring and patient care system that could allow physicians to draw down $41.92 per month for up to 20 minutes of remote care, whilst lowering the massive global cost of diabetes care.Widespread adoption of the ALRT diabetes management program by US physician groups could allow ALRT and its investors to profit significantly from one of the most innovative remote patient monitoring programs available in the US market.
About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their quality goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
Learn more about ALRT: http://www.glntv.tv/alrt
Recent national press coverage on the syndicated Good Life Revolution radio show heard on the Wall Street Business Stations: http://www.viralstocks.com/alr-technologies/
ALRT Homepage: http://alrt.com/
iHookup Social (OTCQB: HKUP), Submits New App Release to Apple, Following Feature Advancement in Apple's iOS8 Platform
Release Includes 'App Preview Video' New From Apple
CAMPBELL, CA--(Marketwired - Oct 6, 2014) - iHookup Social, Inc. (OTCQB: HKUP), a mobile application positioned at the intersection of dating, social media and location-based connections, is pleased to announce that it has submitted a new version of the Company's popular app to Apple for approval and follow-on release.
The newest iHookup Social app is both advent and necessity as the feature set detailed below offers new opportunities for current and future users, as well as keeps pace with Apple's wildly popular new iPhone 6 and the prevailing iOS 8 operating system.
"We continue to advance the product and keep pace with Apple's latest releases," stated Robert Rositano, CEO, iHookup Social, Inc. "These advancements are necessary to maintain usability, as well as enhancing the user experience as Apple continues a rapid fire pace of upgraded operating systems. Each of these advancements, iOS8 compliant fixes and many features should contribute to the maintaining and attracting more users to our community. At the end of September, iHookup Social was in excess of 386,000 registered users."
"Additionally, we are most grateful for a significant opportunity recently granted by Apple, which now allows a video demo of our app (in the Apple App Store), which was previously limited to app screen shots and text only. The significance of having a video demo available to engage a user and promote an install of our app is a tremendous marketing advantage. This addition definitely increases our visibility and should ultimately increase our conversion rates," added Rositano.
According to leading app maker SourceBits, "Video previews are a visually striking and sensory-rich way to show users what your app is about and to convince them to download it. They also provide a great opportunity to demonstrate how to use your app."
Below are detailed specifics of the newest iHookup app submission which are now optimized for iOS 8 and the iPhone 6 and 6 plus:
•iPhone 6 and 6 Plus compatibility
•Multiple iOS 8 Enhancements
•Core experience optimizations (grid, map, menus, pop overs, requests, socialize features and interactive chat / messaging speed)
•Venue and Localized offer integration improvements
•GPS - Location manager optimizations
•In App Notification optimizations
•Data model improvement
•Backend optimizations - Speed / Efficiencies (server side -- API Layers)
•SDK update (Facebook)
•Upgraded Administrative Console
From time to time, iHookup Social will provide market updates and news via its website www.ihookupsocial.com or the Company's Facebook page at www.facebook.com/ihookupnow
iHookup Social, Inc.
iHookup Social, Inc. is a mobile Social Dating App positioned at the intersection of dating, social media and location-based connections.
About iHookup: iHookup endeavors to enable singles, groups and the socially active to connect quickly and efficiently with local, real life 'hook-up' opportunities. This is the iHookup difference. Not only does the company's ever-refining technology help create meaningful connections of all varieties; it also facilitates the real-life meeting and offering-up of locally relevant locations to engage these new connections. These participating venues complete a circle of service that allows iHookup Social to be both matchmaker and concierge, providing a unique opportunity for consumer brands to offer incentives to a growing network of socially active singles and mobile users.
iHookup Social, where real people make real connections... and where real businesses pay to be their host. www.ihookupsocial.com
Highbank- (TSX VENTURE: HBK) Swamp Point North Site and Load-Out Update
VANCOUVER, BC--(Marketwired - October 06, 2014) - Highbank Resources Ltd. (the "Company") (TSX VENTURE: HBK) (FRANKFURT: V70).
President, Victor N. Bryant is pleased to announce:
Swamp Point North Barge loading Facility...
The piling work for the load-out conveyor system is now complete. A total of 24 pilings have been installed with excellent penetration in compacted gravel to average depths of 55 - 65 feet. All pile caps of one inch thick steel have been installed to hold each set of pilings together. The work was completed several days ahead of schedule. Driving of only one piling caused some difficulty when a large boulder was encountered. The piling was re-located and driven without further difficulty.
The Foresight Innovations Ltd. construction crew is now assisting with assembly of the prefabricated conveyor sections and installation on the pilings. Walkways connecting the mooring dolphins will be installed later this week and the conveyor belt and drive installed. A concrete base is being constructed at the feed end of the conveyor to support the aggregate receiving hopper for the load-out system.
Camp and Mine Site Development...
In the mine site area, stripping of the sand/silt layer immediately above the gravel deposit is progressing. Heavy rainfall has slowed this activity; however, this has not prevented flat areas for location of the crushing, washing and screening equipment from being prepared. Weather permitting; Highbank continues to work toward having aggregate ready for shipment in late October/early November 2014. Watch for photo updates and an updated power point presentation on our website at http://www.highbankresources.com
LNG taxation...
Mr. Bryant further comments. As per our September 30, 2014 news release we stated, "The British Columbia Government will conclude negotiations and set forward a fair Liquefied Natural Gas ('LNG') tax regime". As reported in the Vancouver Sun on Thursday, October 2, 2014 titled 'Province signals reductions in planned LNG project taxes'. The governing Liberals return to the legislature on Monday and will table the final tax legislation in the week of October 20, 2014, said Finance Minister Mike de Jong. "These are sizable investments with a lot at stake for the citizens of B.C., and the proponents and we want to get it right," de Jong said. To learn more on this Vancouver Sun article "Province signals reductions in planned LNG project taxes" click on http://urlm.in/tahq
On behalf of the Board of Directors of HIGHBANK RESOURCES LTD.
"Victor N. Bryant"
Victor N. Bryant,
CEO/ President
iHookup Social (HKUP) Continues Its Growth, Exceeding 89,000 Downloads for September and Adding to Overall Registered User Base
Company Posts 7th Consecutive Month of Increased User Growth
CAMPBELL, CA--(Marketwired - Oct 2, 2014) - iHookup Social, Inc. (OTCQB: HKUP), a mobile application positioned at the intersection of dating, social media and location-based connections, is pleased to provide user growth statistics for September of 2014.
For the month of September, the Company showed growth over the previous month of August with a total of 89,970 new downloads of the popular iHookup Social app in the Apple App Store marketplace. This total is another record for the Company as it attracts users to its growing platform, which has now surpassed a total of 386,694 registered users.
January
7,406 New Downloads
120,148 Total Registered Users
February
6,547 New Downloads
124,588 Total Registered Users
March
16,599 New Downloads
137,743 Total Registered Users
April
43,207 New Downloads
164,632 Total Registered Users
May
67,054 New Downloads
212,528 Total Registered Users
June
75,065 New Downloads
257,316 Total Registered Users
July
80,283 New Downloads
308,167 Total Registered Users
August
86,207 New Downloads
353,440 Total Registered Users
September
89,970 New Downloads
386,694 Total Registered Users
"iHookup Social continues to charge forward in our perpetual effort to build a social dating community of significant size, ultimately providing the company with multiple opportunities to monetize this user base and build value for our shareholders," stated Robert Rositano Jr., CEO, iHookup Social. "I am most pleased to state that September was our best month ever by the all-important user growth metric."
"Factor in the roll-out of our Venue based options now available for our users to connect at a local venue, along with the opportunity for local businesses to invite our members in for a real-world visit, and this has been a tremendous month for our app side and operational advancements," added Rositano. "Additionally, we were most pleased to hear of Apple's entry into the wearable tech market with the announcement of their Watch. As we look toward our future expansion we feel this new category is well suited for our technology. In addition to an Android version of our popular app, we believe Apple's investment in this new platform has the potential to greatly expand our market."
From time to time, iHookup Social will provide market updates and news via its website www.ihookupsocial.com or the Company's Facebook page at www.facebook.com/ihookupnow
iHookup Social, Inc.
iHookup Social, Inc. is a mobile Social Dating App positioned at the intersection of dating, social media and location-based connections.
Company Mission: "To enable singles, groups and the socially active to connect quickly and efficiently with local, real life 'hook-up' opportunities."
This is the iHookup difference. Not only does the company's ever-refining technology help create meaningful connections of all varieties; it also facilitates the real-life meeting and offering up of locally relevant locations to engage these new connections. These participating venues complete a circle of service that allows iHookup Social to be both matchmaker and concierge, providing a unique opportunity for consumer brands to offer incentives to a growing network of socially active singles and mobile users.
iHookup Social, where real people make real connections ... and where real businesses pay to be their host. www.ihookupsocial.com
IntelGenx (TSXV: IGX) (OTCQX: IGXT) Founder Returns as President and CEO
Saint Laurent, Quebec--(Newsfile Corp. - October 2, 2014) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx") today announced that its board of directors unanimously decided to appoint the company's founder, Dr. Horst G. Zerbe, as President and Chief Executive Officer. Dr. Zerbe led the company in the same roles from April 2006 to December 2013 and also has been serving as interim President and CEO since July 2014.
"As both a pioneer and expert in drug delivery systems, there is no better decision we could have made than to have Dr. Zerbe return to the helm of IntelGenx, said J. Bernard Boudreau, IntelGenx' Vice-Chairman of the Board. "We are confident in his ability to move the company forward and create shareholder value."
Dr. Zerbe has more than 30 years' experience in Pharmaceutical R&D, technology management, business development and corporate management.
"During my entire professional carrier, and particularly since founding IntelGenx in 2003, it has been my goal to develop novel drug delivery systems that are of significant benefit to patients," said Zerbe. "Although I have remained an integral part of company strategy and operations since its inception, I now look forward to once again leading IntelGenx as we bring our proprietary technologies into new markets and move the company towards revenue growth and profitability."
Prior to founding IntelGenx, Dr. Zerbe served as the president of Smartrix Technologies Inc. in Montreal, and as Vice President of R&D at LTS Lohmann Therapy Systems in West Caldwell, NJ. Dr. Zerbe holds more than 40 patents in drug delivery related fields and has published numerous scientific papers in recognized journals.
Unified Signal / DataJack, Inc. (DJAK) Announces Deployment of First-of-Kind Multi Carrier Share Plan Billing Suite
Kirkland, WA -- (Marketwired) -- 09/30/14 – Unified Signal / DataJack, Inc. (OTCQB: DJAK)), a leading MVNE (Mobile Virtual Network Enabler) in the telecommunications industry, today announced that it has launched new billing functionality to its 17 MVNO clients. This first-of-kind functionality allows clients using the Unified Signal software billing enablement suite to offer their respective customer groups share plans but with a very major differentiator. Customers can now bundle multiple wireless carriers on one bill and share data amongst a group of people regardless of what carrier they are on."
Unified Signal's Chief Executive Officer, Paris Holt, stated, "The trend in the wireless industry is family shares plans. We took this concept and greatly expanded on it. With our new code update that was released last week, our clients can now create and launch shares plans that span multiple inter-personal groups, including families, friends, and businesses. Each of these social/business circles had different functional requirements that we had to code to. Even more significant was our ability to offer this capability across multiple carrier networks within a single group share plan. This is the first time this cross functionality has been accomplished anywhere in the world and it was not an easy task and we are very excited with the end result. This new functionality will provide our MVNO clients with higher profit margins, longer subscriber life cycles, and most importantly, a clear differentiator in the marketplace. It’s important for us to remain on the cutting edge of innovation and with the share plan functionality, I believe we are creating a new standard in the wireless resale industry, which in the end benefits both consumers and MVNOs”
Andrew Yang, Unified Signal’s Director of Carrier Operations, states, "We knew we wanted to enable our clients to offer share plans, but our team wanted a chance to create an industry first. It was not an easy road, but it was worth the 5 months of development work to recode all of our billing and rating procedures to support the new functionality. This cross carrier share strategy will be appealing to businesses as well as residential consumers that can now share plans with friends as well as family members regardless of the carrier network that their phone supports. Groups of people can now share usage across multiple carrier networks, all bundled on one billing account. Since notifying our clients of our initial plans and subsequent progress, the overall response has been extremely positive. As we move from beta testing to our full production launch over the next couple of weeks, our clients can now offer something new and compelling to consumers that has never been done before and our development team has no plans on slowing down. We will be launching more exciting and equally as innovative feature enhancements to the billing system in the months to come.
About Unified Signal
Unified Signal is a SaaS (software as a service) based billing and back office platform, which enables companies in virtually any industry sector to launch cellular, as well as other telecom services using their existing brand. Unified Signal's SaaS platform and infrastructure allows clients to implement faster, have more control over the system with feature rich tools, while being more cost efficient than other solution providers. Unified Signal's turnkey telecom billing platform allows its clients to sell, provision, fulfill, and care for multiple telecom services, including pre and post-paid cellular, local, long distance, Internet, and mobile banking. Unified Signal's SaaS platform is integrated with most major U.S. carriers. The platform also enables clients to private label mobile banking services including a full mobile wallet linked to a prepaid debit card. www.unifiedsignal.com.
Safe Harbor: Statements contained in this news release, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.
IntelGenx (TSX-V:IGX) (OTCQX:IGXT) and RedHill Biopharma Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R)
SAINT LAURENT, Quebec, Oct. 1, 2014 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx"), a Canadian drug delivery company focused on oral drug delivery, today announced, together with RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) ("RedHill"), an Israeli biopharmaceutical company focused on late clinical-stage drugs for inflammatory and gastrointestinal diseases, including gastrointestinal cancers, that they have submitted a Marketing Authorization Application ("MAA") to the German Federal Institute for Drugs and Medical Devices ("BfArM") seeking European marketing approval of their oral thin film formulation of rizatriptan for acute migraines, under the brand name RIZAPORT®. The brand name RIZAPORT® was also conditionally approved by the U.S. Food and Drug Administration ("FDA") as part of the New Drug Application ("NDA") review process in the U.S., subject to a Complete Response Letter ("CRL") received from the FDA in February 2014 and currently under discussions with the FDA.
The MAA was submitted under the European Mutual Recognition Procedure (MRP) with Germany as the reference member state. The submission is supported by several studies, including a recently completed comparative bioavailability study which successfully established the bioequivalence between RIZAPORT® and the European reference drug, Maxalt® Lingua, and follows a positive scientific advice meeting with the BfArM. RIZAPORT® oral thin film does not require the patient to swallow a pill or consume water and presents a potentially attractive therapeutic alternative for many migraine patients, including those who suffer from migraine-related nausea estimated to be approximately 80% of the total migraine patient population1.
IntelGenx and RedHill previously conducted a successful bioavailability study which demonstrated the required FDA criteria for therapeutic bioequivalence between the RIZAPORT® soluble oral thin film and the U.S. reference drug, Maxalt-MLT®. Following the successful bioequivalence study, IntelGenx and RedHill announced in March 2013 the submission to the FDA and acceptance for review of an NDA seeking marketing approval of the product in the U.S., also under the brand name RIZAPORT®. Following a CRL received from the FDA in February 2014, which raised questions primarily related to Chemistry, Manufacturing and Controls ("CMC"), IntelGenx and RedHill reported that they believe that FDA approval of the RIZAPORT® NDA is subject to the satisfactory resolution of the remaining CMC questions, as well as securing a compliant source of the raw material. Accordingly, the companies continue to work with the FDA in order to address and resolve all remaining CMC questions and to secure a compliant source of the raw material.
"We are very pleased with the submission of a European marketing application for RIZAPORT®, which follows our submission of a U.S. New Drug Application currently under discussions with the FDA," said Dr. Elkan Gamzu PhD, RedHill's RIZAPORT® Product Manager. "This regulatory submission in Europe brings us closer to offering a new and potentially advantageous therapeutic alternative for patients suffering from migraines, including those who suffer from migraines with nausea and vomiting. We believe that RIZAPORT® oral thin film's rapid dissolution, pleasant flavoring and ease of use from the ability to administer without water, potentially improves compliance and adherence, and we look forward to making the product available to patients in Europe."
"From a commercial perspective, obtaining marketing authorization in Europe would expand the commercialization of RIZAPORT® into the second largest market of Maxalt®," said Dr. Horst G. Zerbe, President and CEO of IntelGenx. "Pursuing development activities in Europe demonstrates our commitment to bring RIZAPORT® to migraine patients across the world and maximize the value of this asset."
About RIZAPORT®:
RIZAPORT® is a proprietary oral thin film formulation of rizatriptan benzoate, a 5-HT1 receptor agonist and the active drug in Merck & Co.'s Maxalt®. Marketing applications for RIZAPORT® have been filed both in the U.S. (NDA filed in March 2013) and in Europe (MAA filed in October 2014). Rizatriptan is considered one of the most effective oral triptans, a class of molecules that constrict blood vessels in the brain to relieve swelling and other migraine symptoms. The worldwide annual sales of triptans were estimated to have exceeded $1 billion in 20132.
RIZAPORT® is based on IntelGenx' proprietary "VersaFilm™" technology. RIZAPORT® dissolves rapidly and releases its active ingredient in the mouth, leading to an efficient absorption of the drug through the gastro intestinal tract. The administration method of the RIZAPORT® oral thin film does not require the patient to swallow a pill or consume water and presents a potentially attractive therapeutic alternative for many migraine patients, including those who suffer from migraine-related nausea estimated to be approximately 80% of the total migraine patient population3.
About IntelGenx:
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' development pipeline includes products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products. More information is available about the company at www.intelgenx.com.
About RedHill Biopharma Ltd.:
RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) is an emerging Israeli biopharmaceutical company focused on the development and acquisition of late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers. RedHill's current pipeline of proprietary products includes: (i) RHB-104 - an oral combination therapy for the treatment of Crohn's disease, with an ongoing Phase III study; (ii) RHB-105 - an oral combination therapy for the treatment of Helicobacter pylori infection, with an ongoing Phase III study; (iii) RHB-102 - a once-daily oral pill formulation of ondansetron with a Phase III study in the U.S. for acute gastroenteritis and a planned European marketing application for chemotherapy and radiotherapy-induced nausea and vomiting (iv) RHB-106 - an encapsulated formulation for bowel preparation licensed to Salix Pharmaceuticals, Ltd.; (v) MESUPRON® - a Phase II-stage uPA inhibitor, administered by oral capsule, targeting gastrointestinal and other solid tumor cancers; (vi) RP101 - currently subject to an option-to-acquire by RedHill, RP101 is a Phase II-stage Hsp27 inhibitor, administered by oral tablet, targeting pancreatic and other gastrointestinal cancers; (vii) RIZAPORT® (formerly RHB-103) - an oral thin film formulation of rizatriptan for acute migraines with a U.S. NDA currently under discussions with the FDA and a European marketing application submitted in October 2014; and (viii) RHB-101 - a once-daily oral pill formulation of the cardio drug carvedilol. For more information please visit www.redhillbio.com.
1 Lipton RB, Buse DC, Saiers J, Fanning KM, Serrano D, Reed ML. (2013) Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study, Headache. 2013 Jan;53(1):93-103
2 EvaluatePharma, 2013 WW annual sales by pharmacological class, 5-HT1B (serotonin) & 5HT1D (serotonin) agonist
3 Lipton RB, Buse DC, Saiers J, Fanning KM, Serrano D, Reed ML. (2013) Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study, Headache. 2013 Jan;53(1):93-103
ALR Technologies (OTCQB: ALRT), President Bill Smith Discusses the Rapid Changes to Diabetic Care on the "Good Life Revolution" with Jesse Dylan
Richmond, VA and Vancouver, BC / ACCESSWIRE / September 29, 2014 / ALR Technologies Inc. (OTCQB: ALRT), the chronic care medical device company positioned at the forefront of remote patient care, is pleased to announce that company president Bill Smith was a guest on the "Good Life Revolution" with award winning host Jesse Dylan, powered by Megacast. Smith explains how the company's proprietary Health-e-Connect device is paving the way for the future of Remote Patient Care by eliminating complications with patient data and cutting Health Care costs whilst creating a unique pool of profit for the Company.
"We can have clinical experts online looking at a patients data on a regular basis between office visits and the patients wouldn't have to do anything except plug their glucose meter into their computer," Smith explains. The Health-E-Connect device connects patients and Diabetes Care Facilitators through its remote care system.
"It's a way of monitoring a patient's health between office visits and for diabetes patients that's very important," Smith says.
ALRT has recently begun enrolling patients with the Kansas City Metropolitan Physician Association (KCMPA), which is the first large-scale commercial deployment of the Health-e-Connect remote management system. The goal is to lower high-risk glucose levels of some of KCMPA's most challenging diabetic patients.
"Health-e-Connect was designed to help accountable care organizations like KCMPA coordinate patient care among primary care physicians, endocrinologists, and other specialists to improve outcomes," says Smith. "KCMPA is on the forefront of this wave of medical innovation."
The impact of diabetes on a global scale is on the rise; nearly 300 million people are expected to be diagnosed with diabetes by the year 2025 and the total cost of managing the disease in the United States alone is up to $245 billion, including $176 billion in direct medical costs.
"It's a huge issue worldwide…it's exploding in Latin America and it's exploding in Asia. It's really a public health pandemic that's affecting the entire globe," says Smith.
However the adverse cost to monitor diabetes is on track to be offset by the proposed Medicare bill that would see doctors and physicians reimbursed for using technology like ALRT's Health-e-Connect.
"There's a lot of work that happens when the patient isn't physically in the office, so Medicare is proposing to pay physicians to do that work. What it means for our company is that if we are managing a patient behind the scenes [and remotely], the doctors can potentially be paid for that work and in turn pay ALRT for our services," says Smith.
The proposed payment schedule would reimburse physicians $41.92 for 20 minutes of remote chronic care management each month, and the Health-e-Connect is the only off-the-shelf remote chronic care management solution providing physicians to take full advantage of the proposed reimbursement. With Health-e-Connect, physicians and practitioners can meet their quality goals for diabetes care and for the first time receive reimbursement for behind the scenes care.
About MEGACAST
MEGACAST is a 21st Century Digital Branding and Advertising Agency with exclusive expertise in Branding & Design, Content Creation, Viral Marketing and Distribution. In addition to boasting the first Integrated Performance Marketing Strategy all under one roof, the company offers comprehensive Live Streaming capabilities; complete PPV functionality; Digital Marketing, Advertising and Distribution solutions; Web and Mobile Application development, and a combined audience reach of more than 100 million. Businesses spend less, achieve more and save substantial time in the process with the MEGACAST suite of services.
About ALR Technologies Inc.
ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with chronic diseases. ALRT has developed the FDA-cleared and HIPAA compliant Health-e-Connect System that collects data from blood glucose meters and uploads to a secure website. Trained Facilitators use the System to effect efficiency of care among patients, clinicians and caregivers to improve outcomes and assist health plans to optimize their quality goals. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data.
For more information regarding ALRT and the Health-e-Connect system, Please visit http://www.glntv.tv/alrt or http://alrt.com/.
Highbank (HBK.V) Swamp Point North Site Update
VANCOUVER, BC--(Marketwired - September 30, 2014) - Highbank Resources Ltd. (the "Company") (TSX VENTURE: HBK) (FRANKFURT: V7O).
President, Victor N. Bryant updates, onsite inspection September 23, 2014.
Swamp Point North Barge loading Facility….
Transportation of the pilings from the Port of Prince Rupert was received at Swamp Point North on Tuesday, September 23, 2014. Over one-half of the pilings required for the load-out facility have now been installed, placing us approximately 2 weeks ahead of schedule. Installation of the loading conveyor system has commenced, again this is well ahead of schedule.
Camp and Mine Site Development….
Improvement to the site and camp continue. Telephone and internet communications have been established. A camp perimeter electrified bear fence as per site requirements has been installed. Road access development and overburden stripping is proceeding satisfactorily. The region has experienced record rainfall affording on-site environmental personnel to precisely implement the requirements for compliance with water management and other regulations. Despite the extremely high rainfall in the area, development continues well on track. Watch for photo updates and an updated power point presentation on our website at http://www.highbankresources.com
Highbank looks forward to being in the preeminent position of being able to supply aggregates in support of the ongoing construction to the Port of Prince Rupert ($1.2 billion Federal development project). Our contribution will assist in meeting the Federal Government's commitment to make the Port of Prince Rupert, "Canada's Gateway to the Asian Markets". The Company has unwavering confidence in B.C.'s Premier Christy Clark and her Ministers ability to conclude negotiations and set forward a fair Liquefied natural gas ("LNG") tax regime. The B.C. government has stated that the tax regime will be outlined at the opening of the Legislature's fall session October 8, 2014. LNG is an increasingly important pillar of the global energy industry.
On behalf of the Board of Directors of
HIGHBANK RESOURCES LTD.
"Victor N. Bryant"
Victor N. Bryant,
CEO/ President
CrowdGather, Inc. (CRWG) Plaor, Inc. Partners with Side City Studios for Social Casino Content
Plaor, Inc., a wholly-owned subsidiary of vertical interest social media network CrowdGather, Inc. (CRWG), announced today that it has received certain exclusive social casino rights from Side City Studios, Inc. for three video slots, the first of which is expected to launch in the first quarter of 2015.
Plaor, Inc. is licensing video slot content for use in its Mega Fame Casino & Slots™, providing innovative and entertaining gaming content to users by bringing popular slot games from partners like Side City Studios to social and mobile platforms. “We are proud to be partnering with Side City Studios for the continued expansion of our premium slot catalog”, said Richard Corredera, Chief Operating Officer of CrowdGather.
To start playing Mega Fame Casino & Slots™ for free, visit the Facebook App Center, Apple iOS App Store, or Google Play Store now.
About Side City Studios, Inc.
Based in Montreal, Canada, Side City Studios is a third party developer for land based, online and social gaming markets. The company provides full service turnkey solutions to some of the largest gaming companies and, through its partners, Side City Studios distributes its games globally. With its emphasis on high quality premium graphics and unique math models, Side City Studios has developed top performing content.
About CrowdGather, Inc.
With its growing portfolio of special interest forums and enthusiast message board communities, CrowdGather (www.crowdgather.com) has created a centralized network to benefit forum members, forum owners, and forum advertisers. CrowdGather provides a highly interactive and informational social network for members, a management and revenue-sharing resource for third-party forum owners, and a largely untapped advertising network for marketers worldwide.
CrowdGather subsidiary, Plaor, a company that specializes in developing highly scalable multi-platform games, is located in the heart of Boston's fast growing Innovation District. Plaor produces Mega Fame Casino, an innovative and highly rated social casino available on iOS, Android & desktop. With over 20 employees, the Plaor team is a mix of rising-star newcomers and widely-recognized game development veterans from companies including Rockstar Games, Turbine, Harmonix, Irrational Games, Nanigans, Sony Online Entertainment, ThoughtWorks, THQ, and Caesars Interactive Entertainment.
About Mega Fame Casino & Slots™
Mega Fame Casino & Slots™ is a high quality social casino available now on Facebook, iOS, and Android. Users can play more than a dozen unique slot themes, four types of Hold’em poker, video poker, along with the innovative MegaFame Blvd. Mega Fame Casino & Slots™ features more than 300 celebrities and offers weekly celebrity tournaments bringing truly unique star-studded experiences to social games. Based on Plaor’s unaudited financial statements and without the benefit of marketing and advertising resources CrowdGather will provide, Mega Fame Casino & Slots™ currently has more than 20,000 daily active users and generates approximately $1 million in annualized revenues
Eternity Healthcare Inc. (ETAH) Completes Prototype Manufacturing of a Needle-Free Injection Device for Delivery of Vaccine Intramuscularly
VANCOUVER, British Columbia, Sept. 25, 2014 (GLOBE NEWSWIRE) -- Eternity Healthcare Inc. (ETAH), a medical device and diagnostic company with advanced technologies in Needle-Free Injection system, announced today that it has completed a new design of a Needle-Free Injection device. With this new design, doctors will be able to administer vaccines intramuscularly, thus appealing to a larger vaccine market.
Eternity Healthcare Inc. currently has on the market the Comfort-in(TM) Needle-Free Injection System, this device is designed to deliver drugs and medications under the skin (Subcutaneously). The Comfort-in(TM) is not suitable for delivery of vaccines. Most vaccines require injections to be delivered intramuscularly. We have developed a new device, yet to be named, that is in the fore-front of the next generation of Needle-Free delivery. This new technology should appeal to anyone who does not like painful intramuscular injection of vaccines.
Dr. Salari, C.E.O. of Eternity Healthcare Inc. said: "With the recent FDA approval to use a Needle-Free Injection device to administration vaccines, such as Influenza, it opens the door for a large number of injectable vaccines, to be injected without the use of needles." He went on to state: "Using a Needle-Free Injection Device to administer vaccines will not only be less painful, but will eliminate accidental poking and reducing the risk of transmitting diseases. Health Care Workers are always concerned with accidental poking and cross contamination especially when blood is involved."
The World Health Organization estimates that there are over a billion vaccinations administered worldwide each year, that number will increase by a as much as 20% per year. This increase is due to the discovery of additional viruses and associated diseases being recognized and the need for vaccinations increases. For example Ebola, a viral mortal disease, has become an endemic and has alarmed World Wide Health Authorities. Even the United States have become alarmed; President Obama has asked Congress for approval of up to $1 billion to fight Ebola.
About Eternity Healthcare
Eternity Healthcare or the "Company" (ETAH) is a healthcare company with technologies in medical devices and diagnostics. Our most advanced product is a needle-free injection system known as Comfort-inTM. Our products are sold to healthcare professionals, for use in physicians' offices, pharmacies, and to consumers directly. More information on Eternity Healthcare, visit the Company's website; www.eternityhealthcare.com
iHookup Social (HKUP) Extends Marketing Efforts With Launch of Venue Targeted Marketing Initiative
CAMPBELL, CA--(Marketwired - Sep 24, 2014) - iHookup Social, Inc. (OTCQB: HKUP), a mobile application positioned at the intersection of dating, social media and location-based connections, is pleased to announce that it has formally launched its marketing and outreach initiatives to offer local businesses an opportunity to be the venue of choice, for location based connections originating in the Company's app.
Users of the iHookup Social mobile app typically connect based on location, having an initial meeting that is virtual and on their mobile device. Opportunities and incentives are now available for users to offer up a venue based meeting spot or location, sponsored by a participating venue via coupons or other promotions.
"After months of growing our user base and with our venue based marketing collateral now finalized, we are excited to embark on yet another opportunity to drive real social engagement or interaction that translates beyond the virtual connections made in our app. This adds a new dynamic to what can sometimes be an awkward transition from a virtual connection and provides local options for a real life meeting or hookup, so to speak," said Robert Rositano Jr., CEO, iHookup Social. "We are intent on inspiring face-to-face connections at venues and extending additional revenue opportunities for the company."
"In addition to providing a genuine, efficient means to connect to other socially active users, we are pleased to bring the opportunity full-circle by providing a place to connect with a business that greatly values these introductions," added Rositano. "In this case we are both the matchmaker and the concierge in this social equation and frankly, we believe this level of service to our users is unprecedented. These venues may sponsor a promotion or simply begin paying for the coupon or offer upon redemption."
To expedite the circle of commerce, iHookup has perfected both a marketing video and sales brochure to be used in the attraction of various venues.
To view the Local Venue Marketing Video and Sales Brochure please click: http://www.ihookupsocial.com/socialcommerce
An Updated Investor Presentation can be viewed at the link below:
http://www.glntv.tv/ihookup
From time to time, iHookup Social will provide market updates and news via its website www.ihookupsocial.com or the Company's Facebook page at www.facebook.com/ihookupnow
CrowdGather, Inc. (CRWG), Plaor, Inc. Launches Its First Video Slot Title from MultiSlot Ltd
Plaor, Inc., a wholly-owned subsidiary of vertical interest social media network CrowdGather, Inc. (CRWG), announced today the launch of Lucky Luau™, the first social casino title developed from its partner MultiSlot. Lucky Luau™ is a 5 reel video slot with stacked wilds and scatter symbol bonuses and is currently available to play in Mega Fame Casino & Slots™ and on the Facebook, iOS, and Android game platforms.
“We are excited to launch our first title from MultiSlot and introduce Lucky Luau™ to the players of Mega Fame Casino & Slots™, said Richard Corredera, Chief Operating Officer of CrowdGather. “At Plaor, we continue to build a portfolio of licensed video slot games and strategic content partnerships that we believe to be one of the most extensive in the industry.”
MultiSlot co-founder and CEO Eric Jungels added, “We are very optimistic about partnering with Plaor for their Mega Fame Casino & Slots™ application. The union of Plaor’s truly unique social casino platform with MultiSlot’s innovative new game Lucky Luau™ should prove to be a winning combination.”
To start playing Mega Fame Casino & Slots™ for free, visit the Facebook App Center, Apple iOS App Store, or Google Play Store now.
About MultiSlot Ltd.
MultiSlot is an innovative casino and gaming solutions provider based in the Isle of Man. The company has a portfolio of over 70 GLI (Gaming Labs) Certified casino games for real-money gaming, mobile, land based, and social applications and provides robust back-office, custom-development, and game hosting solutions.
About CrowdGather, Inc.
With its growing portfolio of special interest forums and enthusiast message board communities, CrowdGather (www.crowdgather.com) has created a centralized network to benefit forum members, forum owners, and forum advertisers. CrowdGather provides a highly interactive and informational social network for members, a management and revenue-sharing resource for third-party forum owners, and a largely untapped advertising network for marketers worldwide.
CrowdGather subsidiary, Plaor, a company that specializes in developing highly scalable multi-platform games, is located in the heart of Boston’s fast-growing Innovation District. Plaor produces Mega Fame Casino, an innovative and highly rated social casino available on iOS, Android & desktop. With over 20 employees, the Plaor team is a mix of rising-star newcomers and widely recognized game development veterans from companies including Rockstar Games, Turbine, Harmonix, Irrational Games, Nanigans, Sony Online Entertainment, ThoughtWorks, THQ, and Caesars Interactive Entertainment.
About Mega Fame Casino & Slots™
Mega Fame Casino & Slots™ is a high-quality social casino available now on Facebook, iOS, and Android. Users can play more than a dozen unique slot themes, four types of Hold’em poker, video poker, along with the innovative MegaFame Blvd. Mega Fame Casino & Slots™ features more than 300 celebrities and offers weekly celebrity tournaments bringing truly unique star-studded experiences to social games. Based on Plaor’s unaudited financial statements and without the benefit of marketing and advertising resources CrowdGather will provide, Mega Fame Casino & Slots™ currently has more than 20,000 daily active users and generates approximately $1 million in annualized revenues
IntelGenx (TSXV: IGX) (OTCQX: IGXT) to Present at Singular Research 9th Annual Best of the Uncovereds Conference
Saint Laurent, Quebec--(Newsfile Corp. - September 17, 2014) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx") today announced that Dr. Horst Zerbe, Chairman, President and Chief Executive Officer, will present at the Singular Research 9th Annual Best of the Uncovereds Conference to be held Monday, September 22, 2014 at the Luxe Hotel in Los Angeles, California. IntelGenx' presentation will take place September 22, 2014 at 9:30 AM Pacific Time.
Institutional investors that wish to request a meeting with IntelGenx should contact Singular Research.
iHookup to Adapt New App Release for Apple Watch
CAMPBELL, CA, United States, via ETELIGIS INC., 09/10/2014 - - iHookup Social, Inc. (OTCQB: HKUP), a mobile application positioned at the intersection of dating, social media and location-based connections, is pleased to announce its integration initiative to release a streamlined version of its iHookup app to be compatible with "Apple Watch TM," which was announced September 9, 2014 during Apple's annual "Apple Key Note" address.
Wearable technology is a relatively new category that is opening additional opportunities for new social connections, focusing on quick and easy to view features that help improve the experience for users on the go. James McQuivey, a consumer technology analyst for Forrester Research, reported that the Apple Watch had already accomplished one thing, even though it will not be in stores for a while. "It has firmly established the smartwatch as a category, one with unique properties requiring a unique solution as opposed to a miniature smartphone pushed down onto your wrist," he said.
"With Apple's recent announcement of its new "Apple Watch TM" we see many new opportunities to expand our market and build engagement. With the current growth of our iPhone app, wearable tech or "wearable apps" are a category we must embrace," said Robert Rositano Jr., CEO, iHookup Social. "Our app has expanded beyond dating in recent weeks and now incorporates location based recommendations. Today's announcement provides a unique opportunity for our company to be a first mover, allowing us to integrate and release our app upon the release of Apple's new and revolutionary "Apple Watch" due to ship in early 2015.
"These powerful devices worn on the body, allow the iHookup app to deliver a new experience on a very personal screen, catering to singles with yet another option for those looking to maintain their dating and social lives without the need to constantly check their mobile device or computers," added Rositano.
From time to time, iHookup Social will provide market updates and news via its website www.ihookupsocial.com or the Company's Facebook page at www.facebook.com/ihookupnow
A current Investor Presentation can be viewed at the link below: http://www.ihookupsocial.com/overview
Red Eagle Mining (RD.v) Takes Centre Stage In Colorado With 52% Feasibility Study IRR
The gold mining industry has a big week ahead of it—two of its most important conferences will be held in Colorado. From September 14 to 17, the main event is the Denver Gold Forum, which will host the world’s largest precious metals miners, developers, and investors. The Precious Metals Summit, to be held in Vail from September 10 to 12, will focus on earlier stage gold miners.
Red Eagle Mining (RD.v), a Vancouver based firm which owns the Santa Rosa gold project in Colombia, will be presenting at both conferences. They have much to discuss with investors in the audience. A small-ish company, worth about $21 million, Red Eagle has its sights set on cash flowing roughly $50 million in each of 2016 and 2017 (at $1,300/oz gold).
Read the entire article http://ow.ly/BirP7
Levon (LVN.TO) to Present at 4th Annual Euro Pacific Global Investment Conference
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 8, 2014) - Levon Resources Ltd. ("Levon" or "the Company") (TSX:LVN)(FRANKFURT:L09)(BERLIN:L09)(OTCQX:LVNVF) is pleased to announce that the Company will join Peter Schiff and Euro Pacific Capital for the 4th annual Euro Pacific Global Investment Conference on September 9, 2014 at the Sofitel Hotel in New York. Euro Pacific has assembled a group of senior executives from global companies who will offer insights into their own firms as well as their analysis of trends in their respective industries. This year's event includes firms with market capitalizations ranging from $10 million to over $7 billion in the energy, mining, and transportation sectors. Levon's CEO, Mr. Ron Tremblay will be presenting at 9:30 AM on Tuesday, September 9
CrowdGather, Inc. (CRWG) Announces Relaunch of Advisory Board with Gaming Focus
WOODLAND HILLS, Calif.--(BUSINESS WIRE)--
Specialty social media and gaming network, CrowdGather, Inc. (CRWG), today announced that technology and gaming entrepreneurs Paul Bragiel and James Liu will serve as members of CrowdGather’s relaunched advisory board.
“Our recent merger with Plaor, Inc. has revitalized all members of our team and we are delighted to build on that momentum with the relaunch of our advisory board,” said Sanjay Sabnani, Chairman and CEO of CrowdGather, Inc. “Paul Bragiel has been involved with our forum business for several years, but his extensive gaming experience makes him a great advisor to carry forward into this new chapter in our company’s history. Similarly, James Liu also comes to us with a combination of expertise that ranges from enterprise security systems to consumer game development. We feel privileged to have both of these gentlemen anchor our new advisory board.”
Paul Bragiel is a 3 time entrepreneur that has started I/O Ventures, an early stage seed and accelerator fund in Silicon Valley. In addition to his work in the U.S. he has started funds in Africa (Savannah Fund), Asia (Golden Gate Ventures), and Eastern Europe (Gamefounders). Collectively he's invested and advised 100+ companies that have raised $1.5B+ in follow-on financing which includes companies like Uber, Doubledutch and Touch of Modern. In his spare time he is currently advising the countries of Colombia and Georgia on their technology and entrepreneurship policies.
James Liu is the Founder of BoxCat Games. BoxCat is an independently funded game studio located in Los Angeles, CA. James is an experienced project/product/technical manager with a background in Big Data, Enterprise Architecture, and UI/UX. James previously held several titles at Cogent Systems, Inc., one of the world’s leading providers of identity and biometric solutions. At Cogent, James established global procedures, developed remote teams, delivered strategic projects, and established an award-winning commercial products division. In 2010, Cogent Systems, Inc. was acquired by 3M, Inc. BoxCat Games was founded in 2012 with the mission to bring a unique production approach to the mobile game industry.
About CrowdGather, Inc.
With its growing portfolio of special interest forums and enthusiast message board communities, CrowdGather (www.crowdgather.com) has created a centralized network to benefit forum members, forum owners, and forum advertisers. CrowdGather provides a highly interactive and informational social network for members, a management and revenue-sharing resource for third-party forum owners, and a largely untapped advertising network for marketers worldwide.
CrowdGather subsidiary, Plaor, a company that specializes in developing highly scalable multi-platform games, is located in the heart of Boston's fast growing Innovation District. Plaor produces Mega Fame Casino, an innovative and highly rated social casino available on iOS, Android & desktop. With over 20 employees, the Plaor team is a mix of rising-star newcomers and widely-recognized game development veterans from companies including Rockstar Games, Turbine, Harmonix, Irrational Games, Nanigans, Sony Online Entertainment, ThoughtWorks, THQ, and Caesars Interactive Entertainment.
Quest Water Global (QWTR) Proposing Clean Water Solution In Gambia
VANCOUVER, British Columbia--(BUSINESS WIRE)--
Quest Water Global, Inc. (QWTR) ("Quest" and/or "Quest Water" and or "Company"), an innovative water technology company, and developer of the AQUAtap™ Community Drinking Water Station and WEPSTM Atmospheric Water Extraction and Purification System, announced today that the Company is responding to a Request for Proposal (“RFP”) from the Kunta Kinteh Family Foundation to provide a clean water solution for The Village of Jufureh, Republic of The Gambia.
The Kunta Kinteh Family Foundation, with offices in Gambia and the United States, recently invited Quest Water to respond to its Request for Proposal. The objective of the RFP is two-fold: first, to provide a clean source of drinking water for the 2,800 residents of The Village of Jufureh, Gambia, and second, to provide a clean water source for the many International tourists who travel to The Village to visit the birthplace of Kunta Kinteh. In response to the RFP, the Company is pleased to submit a proposal which will include the use of its AQUAtap Community Drinking Water and Distribution Stations to provide a sustainable source of water to both the residents and visitors of the Village.
"We are grateful and honored to have been invited to submit a proposal to the Kunta Kinteh Family Foundation. Gambia is one of the many West African nations that has been in our sights for their lack of clean water, but this RFP allows us to accelerate our potential entry into the country,” said John Balanko, Quest Water CEO & President. “This also affords us the opportunity to commence dialogue with The Gambian Government and governments of neighboring countries, Mali, Senegal, Guinea, Ivory Coast, and Mauritania. We are excited with the prospect of proposing our AQUAtap technology to the Foundation as a sustainable solution for the clean water requirements of the villagers. The opportunity was introduced to us by Mr. Thomas Angell, who heads up our Joint Venture partnership, Global Air Water Resources.”
About Kunta Kinteh Family Foundation
The Kunta Kinteh Family Foundation includes all of the descendants of the late slave, Kunta Kinteh. The Foundation is active in Gambia and the United States. The Kunta Kinteh Family Foundation seeks to improve the lives of those in the West African Village of Jufureh by building a strong infrastructure and providing better opportunities for tourism. Plans also include building a research center to help provide clean drinking water for those in Jufureh and to support school children and, hopefully, to build a health care center. For more information on the Foundation
Levon (TSX:LVN) Announces 848.5 Million Tonnes Grading 41.03 g/t Silver Equivalent Indicated Resource at Cordero...
...Calculated at $20 Per Ounce Silver, Including 488,494,796 Ounces Silver, 1,366,129 Ounces Gold, 9.0 Billion Pounds Zinc and 4.7 Billion Pounds Lead
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 3, 2014) - Levon Resources Ltd. (Levon or the Company) (TSX:LVN)(FRANKFURT:L09)(BERLIN:L09)(OTCQX:LVNVF) announces an updated resource estimate for the Company's 100% owned Cordero project located 35 kilometers northeast of Hildalgo Del Parral, Chihuahua, Mexico. The updated resource estimate reported in this news release is effective September 03, 2014, and takes into account all of the results of the Company's Phase 4 core drilling program completed to date.
The updated Cordero resource is constrained and tabulated within the geometry of a revised open pit, and includes an indicated resource containing 488,494,796 ounces (ozs) silver, 1,366,129 ozs gold, 9.0 billion pounds (B lbs) zinc and 4.7 B lbs lead in 848.5 million tonnes (M t) of material grading 41.03 silver equivalent grams per tonne (g/t) including 17.91 g/t silver, 0.05 g/t gold, 0. 479 percent (%) zinc, and 0.254 % lead, at a cut off grade of 15 g/t silver equivalent. The open pit resource geometry contains an additional inferred resource of 44,448,039 ozs silver, 84,746 ozs gold, 663,311 M lbs zinc, 396,532 M lbs lead within 92,158 million tonnes of material grading 31.4 g/t silver equivalent including 15.00 g/t silver, 0.029 g/t gold, 0.327 % zinc, and 0.195 % lead at a cut off grade of 15 g/t silver equivalent (Table 1). The open pit resource shell measures 2.5 kilometers by 1.6 kilometers and is 600 meters deep with a low overall strip ratio of 1.2:1 waste to mineralized material. A map and cross sections of the open pit may be viewed on Levon's website (www.levon.com).
A summary of the updated resource estimate is shown in Table 1. Resource grades are expressed as silver equivalents, which equate to projected recovered metals. Silver equivalent is calculated using the most recent metallurgical testing recoveries for each metal. The resource shell is defined based on the deductions for mining and operating costs per tonne, including estimated transportation and refining costs for each metal in a projected mill concentrate (Table 2). Silver equivalents are calculated at $20 / oz silver, $1250 / oz gold, 0.94 cents / lb zinc, and 0.95 cents / lb lead.
Table 1. Summary of the September 03, 2014 updated Cordero mineral resource.
Total Resource Contained Metal
Class
Cutoff
AgEq, g/t Tonnes
X1000
AgEq, g/t
Ag, g/t
Au, g/t
Zn, %
Pb, %
Ag oz
Au oz
Zn lbs
X1000
Pb lbs
X1000
Indicated 15 848,462 41.03 17.91 0.050 0.479 0.254 488,494,796 1,366,129 8,952,499 4,742,361
Inferred 15 92,158 31.39 15.00 0.029 0.327 0.195 44,448,039 84,746 663,311 396,532
Table 2. Silver equivalent calculation variables: metal prices, estimated recovery through a standard flotation mill with separate zinc and lead circuits, estimated away from property smelting and refining charges*.
Silver Equivalents Calculation Variables
% Metal Estimated smelter
Metal Metal Price Recovery and refining charges
Ag $ 20.00 85.0 $ 0.024/g
Au $ 1,250.00 18.0 $ 0.00/g
Zn $ 0.94 81.0 $ 0.32/lb
Pb $ 0.95 80.0 $ 0.42/lb
* Costs used to define the resource shell include $6.00/t process cost, $0.75/t G&A, $1.75/t mining cost and the estimated TCRC costs.
"We are pleased with the Company's progress at Cordero, which has advanced quickly from our original discovery in 2009 through four accelerated drill programs to reach the present resource estimate" states Ron Tremblay, President and CEO of Levon Resources Ltd. "The new resource estimate includes a 57% increase in the indicated silver resource over the Company's June 2012 resource estimate" ("Cordero Project June 2012 Mineral Resource Update" dated July 31, 2012 as amended May 10, 2013 prepared by Independent Mining Consultants, Inc. "IMC"). "The resource estimate includes data from holes in the Porphyry Zone and also the Phase 4 drill results from the Aida claim acquired in 2013, which consolidated 100% ownership of the district" (news release April 30, 2014). "The resource expansion across the claim confirms our projections. Owning the entire Cordero district with this large scale discovery is a major accomplishment for our team and Levon shareholders".
Resource Calculations
The Cordero updated resource estimate is tabulated within a revised open pit geometry and was developed from 244 drill holes encompassing 118,937 meters of core drilling, including the latest 41 holes (21,168 m) drilled at the Cordero Project since the Company's announcement of its previous resource estimate in June, 2012. The September 03, 2014 resource remains open to expansion through step out delineation and infill drilling, on strike and beneath the modeled open pit.
The updated Cordero resource estimate presented in this press release was prepared under the direction of Herb Welhner (SME registered member #3434330), Vice President of IMC, who is a qualified person under NI 43-101. IMC has utilized updated metal price projections, estimated metallurgical recoveries, production and processing cost estimates from M3 Engineering & Technology ("M3"), Tucson, Arizona. M3 has revised the prices and costs from their 2012 PEA study ("NI 43-101 Technical Report Preliminary Economic Assessment Chihuahua, Mexico", Issue Date: 8 May 2013, Effective Date: 12 March 2012) filed under Levon's profile at www.sedar.com) to include the recent pre-feasibility stage metallurgical results that improve metal recoveries (Table 2).
Levon expects to file a technical report with respect to the updated resource estimate within 45 days.
Vic Chevillon, Levon's Vice President and Director said "Cordero is a major discovery and a novel porphyry silver, gold, zinc, and lead type system from its alteration and metal zoning patterns. Additional upside potential exists proximal to the resource for contact replacement deposits, in areas yet to be delineated on the margins of the resource. There is also a younger porphyry controlled zinc system in the southwest, and younger porphyry copper and molybdenite mineralization in the northeast part of the resource that has been intersected in deep holes (1,200 m) beneath the presently modeled open pit. At this stage in the discovery, we are pursuing additional metallurgical test work within the new resource to further improve recoveries from early production benches and optimize a start -up operation."
Metallurgy
The latest metallurgical testing designed and managed by M3, and conducted by ALS Metallurgy, Vancouver, B.C., was a pre-feasibility scale study to optimize mill reagents in the modeled standard flotation mill. The mill has separate circuits for zinc and lead. The recoveries were improved over initial metallurgical testing, and gold is now included in the resource estimate.
Qualified Person
Vic Chevillon, AIPG QPG # 11054, the Company's VP, Exploration, Director and a qualified person as such term is defined in NI 43-101 of the Canadian Securities Administrators has reviewed and approved this news release.
Mr. Chevillon has verified the data disclosed in this news release and no limitations were imposed on his verification process. Other than as described below and in the Company's annual filings (which are available at www.sedar.com), there are no known legal, political, environmental or other risks that could materially affect the potential development of the mineral resources at this point in time.
About Levon Resources
Levon is a well-funded gold and precious metals exploration Company, exploring the company's 100% owned flagship Cordero bulk tonnage silver, gold, zinc, and lead project near Hidalgo Del Parral, Chihuahua, Mexico.
For further information, contact the Company IR Direct at 604-682-2991604-682-2991, or main office number 604-682-3701604-682-3701.
ON BEHALF OF THE BOARD
Ron Tremblay, President and Chief Executive Officer
iHookup Social (HKUP) Sets Record for Monthly Downloads, Surpasses 350,000 Total Users
Month Over Month User Growth Continues
CAMPBELL, CA--(Marketwired - Sep 3, 2014) - iHookup Social, Inc. (OTCQB: HKUP), a mobile application positioned at the intersection of dating, social media and location-based connections, is pleased to provide user growth statistics for August of 2014.
For the month of August, the Company showed growth over the previous month of July with a total of 86,207 new downloads of the popular iHookup Social app in the Apple App Store marketplace. This total is another record for the Company as it attracts users to its growing platform, which has now surpassed 350,000 registered users.
January
7,406 New Downloads
120,148 Total Registered Users
February
6,547 New Downloads
124,588 Total Registered Users
March
16,599 New Downloads
137,743 Total Registered Users
April
43,207 New Downloads
164,632 Total Registered Users
May
67,054 New Downloads
212,528 Total Registered Users
June
75,065 New Downloads
257,316 Total Registered Users
July
80,283 New Downloads
308,167 Total Registered Users
August
86,207 New Downloads
353,440 Total Registered Users
"I am pleased to present yet another month of growth in our user base," stated Robert Rositano Jr., CEO, iHookup Social. "Despite constantly testing new ideas that allow us to hone our acquisition methods, we have continued to grow our monthly downloads and the size of our community. Users are the number one priority for the company at this stage of our growth and with a user base that continues to increase, comes additional opportunities for engagement and social interaction."
From time to time, iHookup Social will provide market updates and news via its website www.ihookupsocial.com or the Company's Facebook page at www.facebook.com/ihookupnow
iHookup Social, Inc.
iHookup Social is a "proximity based" mobile social platform that facilitates real connections, between real people... in real time! It utilizes the intelligence of GPS and localized recommendations for dating, friends, groups and organizations to break through closed social cliques and expand them, not only virtually, but in real life!
The company's users will be provided with "local" options of many kinds, enabling mobile distribution of locally relevant content and special offers. The company hopes to bring together a dynamic opportunity for brands, advertisers and merchants to interact in new and innovative ways with the iHookup Social Network, while building customer loyalty, engagement and revenues. The company is pursuing its growth in its current "dating vertical" market, as well as expanding its reach in the general audience category of "Social Networking." www.ihookupsocial.com
iHookup Social (HKUP) Releases App Usage Trending and Engagement Statistics Surpassing Industry Average
CAMPBELL, CA--(Marketwired - Aug 25, 2014) - iHookup Social, Inc. (OTCQB: HKUP), a mobile application positioned at the intersection of dating, social media and location-based connections, is pleased to provide current engagement statistics for users of the Company's popular app.
As detailed in the chart below, the Company's user engagement metrics show session lengths of 50.1 seconds per user which is superior to the average session length of other companies in the mobile -- social industry which report on average, session lengths of 36 seconds per user.
"We are pleased to see our session lengths exceed the industry average," stated Robert Rositano Jr., CEO, iHookup Social. "While user downloads are always our number one focus, subscription and memberships to our premium services are also a critical metric for our industry. We continue to learn from engagement statistics such as these as they provide the company with valuable feedback enabling us to further refine our features for future app releases."
From time to time, iHookup Social will provide market updates and news via its website www.ihookupsocial.com or the Company's Facebook page at www.facebook.com/ihookupnow
iHookup Social, Inc.
iHookup Social is a "proximity based" mobile social platform that facilitates real connections, between real people... in real time! It utilizes the intelligence of GPS and localized recommendations for dating, friends, groups and organizations to break through closed social cliques and expand them, not only virtually, but in real life!
The company's users will be provided with "local" options of many kinds, enabling mobile distribution of locally relevant content and special offers. The company hopes to bring together a dynamic opportunity for brands, advertisers and merchants to interact in new and innovative ways with the iHookup Social Network, while building customer loyalty, engagement and revenues. The company is pursuing its growth in its current "dating vertical" market, as well as expanding its reach in the general audience category of "Social Networking." www.ihookupsocial.com
IntelGenx (TSX-V:IGX) (OTCQX:IGXT) to Present at the Rodman & Renshaw Global Investment Conference
SAINT LAURENT, Quebec, Aug. 21, 2014 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") today announced that Dr. Horst Zerbe, Chairman, President and Chief Executive Officer, will present at the Rodman & Renshaw Global Investment Conference to be held September 9, 2014 at 9:35 a.m. Eastern Time.
The Rodman & Renshaw Conference will take place at The New York Palace hotel on September 8-10, 2014. To learn more about the conference, please visit: http://www.rodm.com
Quest Water Global (QWTR) Releases ‘World Without Water’ Video
Quest Water Global, Inc. (QWTR) ("Quest" and/or "Quest Water" and or "Company"), an innovative water technology company, and developer of the AQUAtap™ Community Drinking Water Station and WEPSTM Atmospheric Water Extraction and Purification System, announced today that the Company has officially released 'World Without Water', a video developed and created to draw global attention to the worldwide water crisis. The video, which is being disseminated and publicized by Viral Network Inc. (“Viral”) and Megacast Media (“Megacast”), focuses on the impact the shortage of safe drinking water is having on the world's most vulnerable populations.
According to the United Nations' World Health Organization unsafe water is responsible for more than three billion cases of illness and five million deaths annually. The death rate for children from the lack of clean drinking water alone is estimated at one every twenty seconds. The video is intended to build mass awareness of the global water crisis and to encourage people to take action by donating to a clean water specific charity.
"We are extremely pleased to play a small part in raising awareness for this untold crisis of our time that kills millions of vulnerable people every year," said John Balanko, Quest Water CEO & President. "'World Without Water' essentially shows us that if we sit back and do nothing the water crisis will only get worse and millions will continue to die. The video was created to draw attention to the issue in a visually appealing and powerful way, and has the potential to get shared extensively through social media networks worldwide.”
The video is available free of charge on YouTube and can be viewed at
H.C. Wainwright Initiates Coverage of Pacific Therapeutics Partner Intelgenx with a Buy Recommendation
Aug 15, 2014 (ACCESSWIRE via COMTEX) -- VANCOUVER, BC, Canada / ACCESSWIRE / August 15, 2014 / Pacific Therapeutics Ltd. (CSE: PT) (OTC Markets: PCFTF) (Frankfurt: 1P3) (the "Company") is a clinical stage specialty pharmaceutical company focused on the repurposing and reformulation of existing FDA approved drugs for large markets. The Company's lead programs focus on diseases of excessive scarring (fibrosis) and erectile dysfunction which are $1 billion plus market opportunities.
H.C. Wainwright & Co. equity analyst Swayampakula Ramakanth, Ph.D. has initiated coverage of IntelGenx Technologies Corp. (IntelGenx) with a buy rating and a target price of $2.00. IntelGenx is partnered with the Company to develop PTL-202 the Company's clinical stage therapy for Idiopathic Pulmonary fibrosis (IPF). The Company and IntelGenx have formulated PTL-202 utilizing the VersaTab technology from IntelGenx.
IntelGenx's Multilayer Tablet: VersaTab
The H.C. Wainwright & Co. report states "IntelGenx has developed a proprietary multilayer tablet technology called VersaTab. VersaTab has the advantage of a higher capacity to load larger amounts of drug that is needed in once-daily formulations. The technology is also versatile enough to have multiple APIs that can be released at different rates. In addition, the technology allows for a cost savings of 50% compared to other oral delivery technologies."
A copy of the initiation report can be accessed by clicking:
https://hcwco.bluematrix.com/docs/pdf/ff51024b-71e2-47c5-ab58-7d05118ab4aa.pdf
ABOUT PACIFIC THERAPEUTICS LTD.
The Company's strategy includes reformulating approved drugs to increase efficacy and patient compliance, while reducing side effects, as well as completing the further clinical testing, manufacturing and other regulatory requirements sufficient to seek marketing authorizations. This strategy may reduce the risk, time and cost of developing therapies by avoiding the risks associated with basic research and using compounds with unknown safety and toxicity profiles.
Pacific Therapeutics Ltd. lead drug candidate for fibrosis (progressive scarring of the organ), PTL-202 is a combination of an FDA approved drug and an amino acid and an extremely potent and important antioxidant. The Company has completed an initial clinical trial of the combination with positive results.
"It's estimated that 45 % of all deaths are related to fibrotic changes" World Health Organization Feb, 2008.
Worldwide, there are over 5,000,000 people living with Idiopathic Pulmonary Fibrosis (IPF), (IPF Coalition). IPF therapy sales across the US, France, Germany, Italy, Spain, and the UK are forecast to rise to over $1.1 billion by 2017, at a Compound Annual Growth Rate (CAGR) of 86.6% (RnR Market Research, 2013). IPF kills more patients per year than either prostate or breast cancer.
For further information visit our website at www.pacifictherapeutics.com or email us at doug.unwin@pacifictherapeutics.com
ABOUT INTELGENX:
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' development pipeline includes products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products. More information is available about the company at Www.Intelgenx.Com.
All reports on IntelGenx prepared by analysts represent the views of such analysts and are not necessarily those of IntelGenx. IntelGenx is not responsible for the content, accuracy or timelines provided by analysts.
Douglas H. Unwin, CEO & President
CrowdGather, Inc. (CRWG), Plaor, Inc. Continues to Grow Its Portfolio of Social Casino Content with the Launch of The Power of Zeus and Frogs n’ Flies
Plaor, Inc., a wholly-owned subsidiary of vertical interest social media network CrowdGather, Inc. (CRWG), announced today the launch of The Power of Zeus™ and Frogs n’ Flies™, the first social casino titles developed from its partners Multicommerce Game Studio and Lightning Box Games Pty Ltd, respectively. Both titles are 5 reel video slots currently available to play in Mega Fame Casino & Slots™ and on the Facebook, iOS, and Android game platforms.
“We are proud to bring two new popular video slot games to the players of Mega Fame Casino & Slots™”, said Richard Corredera, Chief Operating Officer of CrowdGather. “One of Plaor’s goals is to build one of the most extensive and entertaining portfolios of social casino content in the industry and our partnerships with Multicommerce and Lightning Box Games is an integral part of those efforts.”
To start playing Mega Fame Casino & Slots™ for free, visit the Facebook App Center, Apple iOS App Store, or Google Play Store now.
About Multicommerce Game Studio
Multicommerce Game Studio is a leading independent game design studio with more than 10 years of experience in the global gaming industry focused on video slot content, Class II and bingo games. Additionally, Multicommerce Game Studio has a strong background in projects ranging from backend application, SAS development, and the complete development pipeline required for certified Class III game products.
About Lightning Box Games Pty Ltd
Lightning Box is a leading independent slot game design studio based in Sydney, Australia that has been partnering with a growing list of land-based, online, mobile, and social casino clients. Since its formation from IGT and Aristocrat Game designers in 2004, Lightning Box has been providing games for numerous jurisdictions and the company's games can be found on many platforms in online casinos and land based gaming venues throughout the world. Some of the company's partners include Scientific Games/WMS, Amaya, Cozy Games, SG Games, Spielo, Gala Coral, Inspired, JVL, Endemol, Quickfire, Leapfrog, and IGT.
About CrowdGather, Inc.
With its growing portfolio of special interest forums and enthusiast message board communities, CrowdGather (www.crowdgather.com) has created a centralized network to benefit forum members, forum owners, and forum advertisers. CrowdGather provides a highly interactive and informational social network for members, a management and revenue-sharing resource for third-party forum owners, and a largely untapped advertising network for marketers worldwide.
CrowdGather subsidiary, Plaor, a company that specializes in developing highly scalable multi-platform games, is located in the heart of Boston's fast growing Innovation District. Plaor produces Mega Fame Casino, an innovative and highly rated social casino available on iOS, Android & desktop. With over 20 employees, the Plaor team is a mix of rising-star newcomers and widely-recognized game development veterans from companies including Rockstar Games, Turbine, Harmonix, Irrational Games, Nanigans, Sony Online Entertainment, ThoughtWorks, THQ, and Caesars Interactive Entertainment.
About Mega Fame Casino & Slots™
Mega Fame Casino & Slots™ is a high quality social casino available now on Facebook, iOS, and Android. Users can play more than a dozen unique slot themes, four types of Hold’em poker, video poker, along with the innovative MegaFame Blvd. Mega Fame Casino & Slots™ features more than 300 celebrities and offers weekly celebrity tournaments bringing truly unique star-studded experiences to social games. Based on Plaor’s unaudited financial statements and without the benefit of marketing and advertising resources CrowdGather will provide, Mega Fame Casino & Slots™ currently has more than 20,000 daily active users and generates approximately $1 million in annualized revenues.
Highbank (TSX VENTURE: HBK) Closes 2nd Tranche - $1.3 Million Convertible Debenture and Swamp Point North Progress Update
VANCOUVER, BC--(Marketwired - August 08, 2014) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Highbank Resources Ltd. (TSX VENTURE: HBK)(FRANKFURT: V7O), (the "Company") is pleased to announce the closing of the 2nd tranche of its $1.3 million convertible debenture, as its Swamp Point North aggregate project moves closer to production.
Swamp Point North -project update
Mr. Victor N. Bryant, President/CEO reports: V.P. Operations Mr. Stan Spletzer, is presently onsite assisting in planning for preparation of stripping and mining activities; and for installation of the crushing and washing plant equipment. Final discussions are taking place with the pile driving company-part of the barge load-out facility, which we expect to be on site in the latter part of this month.
Convertible Debenture
Highbank closes the 2nd tranche -$1.3 million of our total $4 million convertible debenture financing.
The convertible debentures bears interest at the rate of 10% per annum and has a term of three years for repayment by the Company from revenues earned through the sale of aggregate from the Swamp Point North aggregate project. The debentures are convertible into shares of the Company at a price of $0.45 during the first year, $0.35 during the second year, and at a price of $0.25 in the third year.
The Company is paying cash finder's fees equal to 7-1/2% on a portion of the gross proceeds raised from the convertible debentures or $82,500 and 22,727 shares at a deemed price of $0.33 per share.
On Behalf of the Board of Directors of
HIGHBANK RESOURCES LTD.
"Victor N. Bryant"
Victor N. Bryant,
CEO/President
IntelGenx (TSXV: IGX) (OTCQX: IGXT) Reports Q2, 2014 Results and Provides Corporate Development Update
Saint Laurent, Quebec--(Newsfile Corp. - August 7, 2014) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx") today announced financial results for the three and six months ended June 30, 2014 and provided an update on corporate developments. All amounts are in U.S. Dollars, unless otherwise stated.
Financial Results:
Cash on hand at June 30, 2014 increased to $5.2 million and compares with a cash balance of $5.0 million as at December 31, 2013. The increase in cash on hand at the end of Q2, 2014 relates to net cash provided by financing activities of $1.6 million (2013 - $0.8 million) and relates to the exercise of warrants, partly offset by net cash used in operating activities of $1.2 million (2013 - $0.3 million) and net cash used in investing activities of $0.2 million (2013 - $0.2 million).
Revenue of $0.4 million during the six months ended June 30, 2014 (2013 - $0.7 million) primarily relates to revenue generated by Forfivo XL®, our first product approved by the U.S. Food and Drug Administration ("FDA"). Revenue generated in the first six months of 2013 included project related development milestones totaling $0.5 million for the successful completion of the pivotal bioequivalence study for our VersaFilm™ buprenorphine/naloxone product for the treatment of opiate addiction and confirmation that our New Drug Application ("NDA") submission to the FDA for our anti-migraine VersaFilm™ oral film product was sufficiently complete to permit a substantive review.
Total expenses in the first six months of 2014 were $1.5 million compared with $1.1 million in the same period of 2013. The increase relates primarily to an increase in R&D expenses for costs of a pilot clinical study for our VersaFilm™ product for erectile dysfunction that indicated bioequivalence with the leading brand reference listed drug tadalafil product, together with costs incurred in the development of our second Par project, which is progressing according to plan.
The net loss increased from $0.4 million in the first six months of 2013 to $1.1 million in the same period of 2014. The loss per share was $0.01 in the first six months of 2013 and $0.02 in the first six months of 2013.
Corporate Development Update
Equity Analyst Coverage by H.C. Wainwright
Subsequent to the end of the quarter, on July 1, 2014 we announced that H.C. Wainwright initiated equity analyst coverage of IntelGenx with a "buy" rating and price target of $2. The stock closed at US$0.70 on the OTCQX and at CAD$0.74 on the TSX-V on Friday, June 27, 2014.
A copy of the initiation report can be accessed by clicking:
https://hcwco.bluematrix.com/docs/pdf/ff51024b-71e2-47c5-ab58-7d05118ab4aa.pdf.
All reports on us prepared by analysts represent the views of such analysts and are not necessarily those of IntelGenx. We are not responsible for the content, accuracy or timelines provided by analysts.
Anti-migraine VersaFilm™ product
On February 4, 2014, together with our co-development partner RedHill Biopharma Ltd. ("RedHill"), we announced receipt of a Complete Response Letter ("CRL") from the FDA regarding the NDA for our VersaFilm™ product for the treatment of acute migraines. The CRL cited regulatory compliance issues with a supplier of raw materials for the product as an impediment to FDA approval. Since receiving the CRL, we have been diligently working on a variety of options to ensure continued supply of the raw material and have already identified and audited an alternative source of active pharmaceutical ingredient ("API"). Furthermore, IntelGenx and RedHill are preparing to manufacture the batches required for the CRL response and to conduct the stability studies that are required to support the switch to the new API.
On April 28, 2014 IntelGenx and RedHill announced the commencement of a comparative bioavailability clinical study comparing the anti-migraine VersaFilm™ product to the European reference drug, Maxalt® lingua, marketed in Germany by MSD SHARP & DOHME GMBH. In light of the positive results from the bioavailability study, together with data from prior clinical studies, IntelGenx and RedHill plan to submit a European Marketing Authorization Application ("MAA") during the third quarter of 2014.
Government Funding for CNS VersaFilm™ product
On April 30, 2014 we announced financial support from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to support further development of a product for the treatment of central nervous system (CNS) diseases and disorders. The product will be based upon our proprietary, oral thin film, VersaFilm™, technology.
In order to maintain our competitive advantage, no specific details related to this project are being disclosed at this time.
U.S. patent allowances
On February 26, 2014 we announced receipt of a Notice of Allowance ("NOA") from the United States Patent and Trademark Office ("USPTO") for U.S. Patent Application Serial No. 11/647,033 entitled "Multilayer tablet" which covers the technology used in our hypertension product currently under development. A second NOA has been received for U.S. Patent Application Serial No. 11/782,838 entitled "Controlled-release pharmaceutical tablets" which is related to the drug delivery technology used in Forfivo XL®, our first FDA-approved product currently commercialized in the U.S.
On April 16, 2014 we announced receipt of a further NOA from the USPTO for U.S. Patent Application Serial No. 12/836,810 entitled "Oral mucoadhesive dosage form" which covers IntelGenx' proprietary AdVersa™ mucoadhesive drug delivery technology.
Management Changes
Subsequent to the end of the quarter, on July 15, 2014 we announced that the board of directors (the "Board") of IntelGenx had accepted the resignation of Dr. Rajiv Khosla as President, Chief Executive Officer, and as a member of the Board. The Board immediately appointed Dr. Horst G. Zerbe to serve as our interim President and Interim CEO until a successor is found.
About IntelGenx:
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' development pipeline includes products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products. More information is available about the company at www.intelgenx.com.
Altima's (TSX-V: ARH / FSE: AKC /OTC Pink: ARSLF) Commences Workover Operations on the 3-17-41-11 W5M Well at Chambers-Ferrier, Alberta
Vancouver, BC / TNW-ACCESSWIRE / August 6, 2014 / Altima Resources Ltd. (TSX-V: ARH / FSE: AKC / OTC Pink: ARSLF) announces that it has commenced workover operations on the UNE Chambers 3-17-41-11 W5M well (the "Well"), located in the Chambers-Ferrier area of the Western Sedimentary Basin, Alberta.
Altima has assumed Operatorship of the Well and will re-enter the well bore, remove existing packers and WR plugs, run tubing, and place the Well on production. The Well will produce through an existing flowline to the Conoco 9-4-41-11 W5M compressor station, which is tied into the Keyera Deep Cut Gas Processing Plant at Strachan.
The Well was originally drilled by Golden Eagle Exploration to a Total Depth of 3,349 meters and rig released in June 2006. In July-August 2006, the Well was perforated and fracture stimulated in the Rock Creek and tested at a rate of 300 MSCF/D. The Rock Creek was then suspended and the Well recompleted in the Ellerslie sands. In November 2007, the Well was placed on production, and produced through to March 2009. The Ellerslie sands were then suspended and the Second White Specks Formation perforated, after which the Well was left shut in. The current workover will commingle all intervals to enable placing the Well back on production.
The Well workover is being completed under Altima's Participation Agreement with Acumen Energy Partners Inc. (refer to news release dated January 30, 2014).
The Company's mostly contiguous land base at Chambers-Ferrier totals twenty-seven (27) sections (17,280 gross acres) with an approximate average working interest of 86% in 16 of the 27 sections and varying interests in eleven (11) wells.
Richard Switzer, CEO, President and a Certified Professional Geologist, is the Qualified Person under National Instrument 51-101 responsible for preparing and reviewing the data contained in this press release.
ON BEHALF OF THE BOARD
SIGNED: "Richard Switzer"
Richard Switzer, CEO and President
Quest Water (OTCQB:QWTR) and Hudson Dekker in Discussions for Licensing Agreement in Nigeria
Vancouver, British Columbia (FSCwire) - Quest Water Global, Inc. (OTCQB:QWTR) ("Quest" and/or "Quest Water" and/or "Company"), an innovative water technology company, and developer of the AQUAtapTM Community Drinking Water Station and WEPSTM Atmospheric Water Extraction and Purification System, announced today that the Company is in discussions with Nigerian social infrastructure project experts Hudson Dekker Limited to distribute its products in Nigeria. The initial phase of the multi-year Licensing Agreement would see the establishment of a 10-unit AQUAtapTM pilot project by Hudson Dekker within 12 months.
“We intend to finalize the terms of the Nigerian Licensing Agreement when we return to Africa this Fall,” said Mr. Peter Miele, Quest Water Executive Vice President, “Hudson Dekker has been monitoring our work in Angola and is extremely excited to meet with us while we are there to further our negotiations regarding the distribution of our products in Nigeria and other African countries. They have extensive experience with social infrastructure projects in the region with a primary focus on the Education and Health Sectors.”
“We are looking forward to the opportunity to distribute Quest Water’s clean water technology to water scarce regions in Nigeria and other nearby countries,” said Abdul Rahman Yesufu, Founder and Managing Partner of Hudson Dekker Limited. “Once the Licensing Agreement is complete we intend to run a 12-month pilot program using Quest Water's proprietary AQUAtapTM Community Drinking Water Stations."
The Company intends to finalize the multi-year Licensing Agreement for Nigeria with Hudson Dekker by the 4th Quarter of 2014. Details of that Agreement, including sales targets, will be forthcoming.
About Hudson Dekker Limited
Hudson Dekker Limited is a wholly owned Nigerian firm focused on delivering next generation solutions developed specifically for education, health, and other sectors, that affect the social infrastructure space in Nigeria. The company has offices in Lagos, the commercial capital, and Abuja, Nigeria. The primary activity of the Company is investment in publicly and privately financed social infrastructure solutions development and delivery across the country, with emphasis on rural communities.
Infrastructure development in Nigeria is relatively new from a public private partnership (PPP) perspective as most of the available infrastructure until recently was funded and managed solely by the Federal and State governments. However, due to the limited resources available to both levels of government, it has become necessary for private investors to partner with government authorities to ensure that the right infrastructure is provided for the general public and rural communities at affordable prices. Most of the projects currently being developed under the PPP concept are critical infrastructure projects such as roads, bridges, airports, major water schemes, and energy power grids. Hudson Dekker sees a unique opportunity in focusing on improving the social service infrastructures such as education, healthcare, and potable water in rural communities.
About Quest Water Global, Inc.
Quest Water Global Inc., and its wholly-owned operating subsidiary Quest Water Solutions Inc., is an innovative water technology company that provides sustainable and environmentally sound solutions to water scarce regions. We use proven technologies to create economically viable products that address the critical shortage of clean drinking water in developing countries. Our goal is to provide an alternative, sustainable source of pure water at the smallest possible environmental cost, while becoming a leading company in providing turn-key solutions using alternative energy for the purification, desalination, and distribution of clean drinking water
IntelGenx (TSX-V:IGX) (OTCQX:IGXT) to Host Management Call
SAINT LAURENT, Quebec, July 18, 2014 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") today announced that its interim CEO, Dr. Horst G. Zerbe, will be hosting a conference call on July 23rd, 2014 at 10:00 AM Eastern Time.
During the conference call, Dr. Zerbe will provide a business update and discussion regarding the Company's recent management changes. After management's comments, the call will be opened for questions.
An accompanying webcast will also be provided. Please refer to the information below for conference call dial-in information and webcast registration.
Conference dial-in: 877-269-7756
International dial-in: 201-689-7817 7817
Conference Call Name: IntelGenx Management Update Call
Webcast Registration: CLICK HERE (http://w.on24.com/r.htm?e=827651&s=1&k=32D198D6AB7E398E72BDE0D6DF0CB7CC)
Following the live call, a replay will be available on the Company's website, www.intelgenx.com, under "Investor Relations".
About IntelGenx:
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' development pipeline includes products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products. More information is available about the company at www.intelgenx.com.
Altima Resources Ltd. (ARH.V) Altima's Chambers 5-35-41-11 W5M Well On-Stream
July 17, 2014 / Altima Resources Ltd. (TSX-V: ARH / FSE: AKC / OTC Pink: ARSLF) announces that the Altima Chambers 5-35-41-11 W5M well (5-35 well) was placed on-stream July 16, 2014.
The 5-35 well was drilled to a Total Depth (TD) of 3,158 meters Measured Depth and Rig Released (RR) on March 16, 2014. Altima completed a 1.37 kilometer, 4 inch natural gas pipeline from the 5-35 well to a newly constructed riser located at 9-35-41-11 W5M. This infrastructure connects the 5-35 well into Altima's existing Chambers North production and gathering system.
As reported in the Company's March 3, 2014 News Release, the 5-35 well is the second well drilled under Altima's Participation Agreement with Whistler Oil and Gas Pty. Ltd. The 5-35 well is located approximately 1.1 kilometers south of the 15-35-41-11 W5M well (which was drilled, completed, and placed on production in 2013), and 4 kilometers to the north of the COPOL ET AL HZ CHAMBERS 14-15-41-11 W5M well (which was drilled and completed in 2012, and placed on production in 2013).
The Company's mostly contiguous land base at Chambers-Ferrier totals twenty-seven (27) sections (17,280 gross acres) with an approximate average working interest of 86% in 16 of the 27 sections and varying interests in eleven (11) wells.
Richard Switzer, CEO, President and a Certified Professional Geologist, is the Qualified Person under National Instrument 51-101 responsible for preparing and reviewing the data contained in this press release.
ON BEHALF OF THE BOARD
SIGNED: "Richard Switzer"
Richard Switzer, CEO and President
IntelGenx Announces Management Changes
SAINT LAURENT, Quebec, July 15, 2014 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") announced today that the board of directors (the "Board") of IntelGenx has accepted, with immediate effect, the resignation of Dr. Rajiv Khosla as President and Chief Executive Officer ("CEO") of IntelGenx and as a member of the Board.
Effective immediately, the Board has appointed Dr. Horst G. Zerbe to serve as IntelGenx' interim President and CEO until a successor is found. A Search Committee has been formed by the Board to begin the search, selection and appointment of a new President and CEO.
Dr. Zerbe is the Chairman of the Board, founder, and former President and CEO of IntelGenx. He retired from the positions of President and CEO effective December 31, 2013. However, Dr. Zerbe retained an active role in IntelGenx' operations throughout the past six and a half months, providing expertise in the areas of research and development, and manufacturing.
The Board thanks Dr. Khosla for his service and contributions to the company and wishes him well in his future endeavours
IntelGenx (TSX-V:IGX) (OTCQX:IGXT) Announces Equity Analyst Coverage by H.C. Wainwright
SAINT LAURENT, Quebec, July 1, 2014 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") today announced that H.C. Wainwright has initiated equity analyst coverage of IntelGenx.
H.C. Wainwright initiated coverage of IntelGenx with a "buy" rating and price target of $2. The stock closed at US$0.70 on the OTCQX and at CAD$0.74 on the TSX-V last Friday.
A copy of the initiation report can be accessed by clicking: https://hcwco.bluematrix.com/docs/pdf/ff51024b-71e2-47c5-ab58-7d05118ab4aa.pdf.
All reports on IntelGenx prepared by analysts represent the views of such analysts and are not necessarily those of IntelGenx. IntelGenx is not responsible for the content, accuracy or timelines provided by analysts.
About IntelGenx:
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. IntelGenx uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films. IntelGenx' development pipeline includes products for the treatment of indications such as severe depression, hypertension, erectile dysfunction, migraine, insomnia, CNS indications, idiopathic pulmonary fibrosis, oncology and pain, as well as animal health products
Hey JunkHustler
I loved it at .14 Look at it today we are testing the 52 week high at .21 so I'm very happy right now. I do see this as a long term play,
Highbank (TSX VENTURE:HBK) Mobilizes and Commences Site Development at Swamp Point North
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 26, 2014) - Highbank Resources Ltd. (TSX VENTURE:HBK)(FRANKFURT:V7O), (the "Company").
Mr. Victor N. Bryant, CEO reports another milestone in our development of Swamp Point North…
The first tug and barge load of equipment and supplies will depart the Port of Prince Rupert this morning approximately 10:30 a.m. PST, travelling north to Swamp Point. The tug and barge will be transporting the Company and Contractors D5 Cat, 225 Excavator c/w various attachments, a 330B Case Rock Truck, 5000 gallon fuel tank, the 4th Atco trailer (containing dry room, showers, washrooms and laundry), and general camp materials for site preparation. Highbank's 6-person crew will also be launching the Company's work boat from Stewart, B.C. to travel south 38 miles to rendezvous with the tug and barge at Swamp Point North to commence offloading of equipment at approximately 1 p.m.PST Friday, June 27, 2014. The 6 person crew will remain on site and proceed with the camp and site preparation. Additional equipment will be transported to the site in the coming weeks.
To view todays video news release presentation click on…